Merck Manual

Please confirm that you are a health care professional

honeypot link



Paschalis Vergidis

, MD, MSc, Mayo Clinic College of Medicine & Science

Reviewed/Revised Sep 2023

Phaeohyphomycosis refers to infections caused by many kinds of dark, melanin-pigmented dematiaceous fungi. It is distinguished from chromoblastomycosis and mycetoma by the absence of specific histopathologic findings.

Phaeohyphomycosis can be caused by many species of dark, melanin-pigmented dematiaceous fungi including Bipolaris, Cladophialophora, Cladosporium, Exophiala, Fonsecaea, Phialophora, Ochronosis, Rhinocladiella, and Wangiella.

Although some species of these fungi may be true pathogens and cause phaeohyphomycosis in immunocompetent patients, pigmented fungi have been increasingly recognized as opportunists; almost all cases of widely disseminated infection occur in immunosuppressed patients. Dematiaceous fungi only rarely cause fatal infections in patients who have intact host defense mechanisms, although certain species may cause brain abscess in immunocompetent patients.

Clinical syndromes include invasive sinusitis, sometimes with bone necrosis, as well as subcutaneous nodules or abscesses, keratitis, lung masses, osteomyelitis, mycotic arthritis, endocarditis, brain abscess, and disseminated infection.

Diagnosis of Phaeohyphomycosis

  • Examination using Masson-Fontana staining

  • Culture to identify causative species

Dematiaceous fungi can frequently be discerned in tissue specimens stained with conventional hematoxylin and eosin; they appear as septate, brownish hyphae or yeast-like cells, reflecting their high melanin content. Masson-Fontana staining for melanin confirms their presence. Phaeohyphomycosis is distinguished from chromoblastomycosis and mycetoma by the absence of specific histopathologic findings such as sclerotic bodies or grains in tissue.

Culture is needed to identify the causative species.

Treatment of Phaeohyphomycosis

  • For subcutaneous nodules, surgery and/or itraconazole

  • For brain abscess or disseminated infections, a combination of antifungals

There is no standard therapy; treatment of phaeohyphomycosis depends on the clinical syndrome and status of the patient.

For subcutaneous nodules, surgery alone may be curative. Itraconazole has excellent activity and has been used the most clinically, although voriconazole and posaconazole are being increasingly used with good results. Duration of therapy varies but may range from 6 weeks to > 12 months. Amphotericin B is often ineffective.

For brain abscess, treatment should include surgical resection if possible.

For brain abscess or disseminated infections, combination therapy (eg, with 2 or 3 medications, at least one of which is an azole) is often used, although clinical outcomes are generally poor regardless of treatment.

Drugs Mentioned In This Article

Drug Name Select Trade
Amphocin, Fungizone
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz!